|Awarded On||August 17, 2016|
|Title||Towards Carbon Beam Stereotactic Body Radiation Therapy (C-SBRT) for Higher Risk Early Stage Lung Cancer|
|Award Mechanism||Multi-Investigator Research Awards (Version 2)|
|Institution/Organization||The University of Texas Southwestern Medical Center|
|Principal Investigator/Program Director||Steve Jiang|
|Cancer Sites||Lung and Bronchus|
Lung cancer is the second most common type of cancer and the number one cause of cancer death in the United States. About 90% of lung cancers are non-small cell lung cancer (NSCLC). Patients with NSCLC may be treated with surgery, radiation therapy, chemotherapy, or a combination of these therapies. Radiation therapy continues to be the primary treatment for 60% of patients. Stereotactic body radiotherapy (SBRT) is a radiotherapy method that delivers a high dose of radiation to the cancer target with a high degree of precision through a small number of fractions. Over the years, SBRT has been successfully employed to early stage NSCLC using megavoltage X-ray beams. Clinical trials have clear...